Myolex
Christi Flynn Wilkerson is a seasoned professional with extensive experience in product management and leadership roles across various industries. Currently serving as Senior Director for myMedidata at Medidata Solutions since 2020, Christi also holds positions as an investor and advisor at Myolex. Prior roles include Director of Product at Science 37, Head of Product at WebMD Health Services, and Global Product Director for Digital Innovation at Nike. With a strong foundation in technology and marketing from Apple, Napster Group, and Creative Labs, Christi possesses a diverse skill set in product development and innovation. Christi holds a degree in Innovation and Entrepreneurship from Stanford University, alongside a degree in Education from Oklahoma State University, complemented by education from MIT Sloan School of Management.
This person is not in any teams
Myolex
Myolex is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries. Myolex® EIM is a patented device technology and SaaS data analytics platform that is built to disrupt skeletal muscle measurement by becoming the clinical and wellness standard to aid in the diagnosis and treatment of obesity drug and age-related muscle wasting. Myolex has developed the 1st quantitative, sensitive, painless, portable for home use muscle quality assessment device that is specifically designed to non-invasively, comprehensibly, and precisely detect and monitor single muscle wasting.